FDA Proposes Rule on Clinical Investigator Financial Disclosure

Summary

The US Food and Drug Administration (FDA) is proposing a new rule requiring pharmaceutical companies to disclose the financial interests of clinical investigators involved in human clinical trials. The rule aims to ensure that the compensation and interests of these investigators do not influence the results of the trials.